The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Striatonigral Degeneration

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Striatonigral Degeneration

 

Psychiatry related information on Striatonigral Degeneration

 

High impact information on Striatonigral Degeneration

 

Chemical compound and disease context of Striatonigral Degeneration

 

Anatomical context of Striatonigral Degeneration

 

Gene context of Striatonigral Degeneration

 

Analytical, diagnostic and therapeutic context of Striatonigral Degeneration

References

  1. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Goto, S., Hirano, A., Matsumoto, S. Neurology (1990) [Pubmed]
  2. Neuroleptic malignant syndrome in striatonigral degeneration. Gibb, W.R. The British journal of psychiatry : the journal of mental science. (1988) [Pubmed]
  3. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy). Puschban, Z., Waldner, R., Seppi, K., Stefanova, N., Humpel, C., Scherfler, C., Levivier, M., Poewe, W., Wenning, G.K. Exp. Neurol. (2000) [Pubmed]
  4. Alpha-synuclein binding to rab3a in multiple system atrophy. Dalfó, E., Ferrer, I. Neurosci. Lett. (2005) [Pubmed]
  5. Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients. Sawada, M., Nagatsu, T., Nagatsu, I., Ito, K., Iizuka, R., Kondo, T., Narabayashi, H. J. Neural Transm. (1985) [Pubmed]
  6. Brain glutathione peroxidase in neurodegenerative disorders. Kish, S.J., Morito, C.L., Hornykiewicz, O. Neurochemical pathology. (1986) [Pubmed]
  7. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Eidelberg, D., Takikawa, S., Moeller, J.R., Dhawan, V., Redington, K., Chaly, T., Robeson, W., Dahl, J.R., Margouleff, D., Fazzini, E. Ann. Neurol. (1993) [Pubmed]
  8. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. De Volder, A.G., Francart, J., Laterre, C., Dooms, G., Bol, A., Michel, C., Goffinet, A.M. Ann. Neurol. (1989) [Pubmed]
  9. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Fernagut, P.O., Diguet, E., Bioulac, B., Tison, F. Exp. Neurol. (2004) [Pubmed]
  10. Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. Shinotoh, H., Inoue, O., Hirayama, K., Aotsuka, A., Asahina, M., Suhara, T., Yamazaki, T., Tateno, Y. J. Neurol. Neurosurg. Psychiatr. (1993) [Pubmed]
  11. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. Ghorayeb, I., Puschban, Z., Fernagut, P.O., Scherfler, C., Rouland, R., Wenning, G.K., Tison, F. Exp. Neurol. (2001) [Pubmed]
  12. A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. Ghorayeb, I., Fernagut, P.O., Hervier, L., Labattu, B., Bioulac, B., Tison, F. Neuroscience (2002) [Pubmed]
  13. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Ghorayeb, I., Fernagut, P.O., Aubert, I., Bezard, E., Poewe, W., Wenning, G.K., Tison, F. Mov. Disord. (2000) [Pubmed]
  14. Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases. Nagatsu, T., Yamaguchi, T., Rahman, M.K., Trocewicz, J., Oka, K., Hirata, Y., Nagatsu, I., Narabayashi, H., Kondo, T., Iizuka, R. Advances in neurology. (1984) [Pubmed]
  15. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Kim, Y.J., Ichise, M., Ballinger, J.R., Vines, D., Erami, S.S., Tatschida, T., Lang, A.E. Mov. Disord. (2002) [Pubmed]
  16. Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys. Ghorayeb, I., Fernagut, P.O., Stefanova, N., Wenning, G.K., Bioulac, B., Tison, F. Neurosci. Lett. (2002) [Pubmed]
  17. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. Strijks, E., van't Hof, M., Sweep, F., Lenders, J.W., Oyen, W.J., Horstink, M.W. J. Neurol. (2002) [Pubmed]
  18. Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy). Mantoan, L., Stefanova, N., Egger, K.E., Jellinger, K.A., Poewe, W., Wenning, G.K. Acta Neuropathol. (2005) [Pubmed]
  19. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Waldner, R., Puschban, Z., Scherfler, C., Seppi, K., Jellinger, K., Poewe, W., Wenning, G.K. Neuroscience (2001) [Pubmed]
 
WikiGenes - Universities